Literature DB >> 2245609

Does prematurity alter the course of respiratory syncytial virus infection?

K Meert1, S Heidemann, B Abella, A Sarnaik.   

Abstract

We compared previously healthy prematurely born infants with full-term infants hospitalized with respiratory syncytial virus (RSV) infection to evaluate the role of prematurity on the clinical course of the illness. During a 5-yr period (1984 to 1989), 484 previously healthy patients were admitted to the hospital with RSV infection. No differences were found in the presenting symptoms of respiratory distress, cough, fever or shock, although the premature group was more likely to present with apnea (p less than .001). Chest roentgenograms revealed that premature infants had a higher incidence of atelectasis/infiltrate and hyperinflation (p less than .05). Premature infants had longer hospital stays as well as a higher Physiologic Stability Index and Therapeutic Intervention Score (p less than .001). They were also more likely to receive supplemental oxygen, ICU admission, mechanical ventilation, and nothing by mouth status (p less than .001). We conclude that premature birth increases the risk of more severe and prolonged RSV disease.

Entities:  

Mesh:

Year:  1990        PMID: 2245609     DOI: 10.1097/00003246-199012000-00009

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  22 in total

Review 1.  Current research on respiratory viral infections: Third International Symposium.

Authors:  A C Schmidt; R B Couch; G J Galasso; F G Hayden; J Mills; B R Murphy; R M Chanock
Journal:  Antiviral Res       Date:  2001-06       Impact factor: 5.970

2.  Respiratory syncytial virus infection in high risk infants and the potential impact of prophylaxis in a United Kingdom cohort.

Authors:  S J Clark; M W Beresford; N V Subhedar; N J Shaw
Journal:  Arch Dis Child       Date:  2000-10       Impact factor: 3.791

3.  Burden of respiratory syncytial virus infection in young children.

Authors:  Bernhard Resch
Journal:  World J Clin Pediatr       Date:  2012-10-08

4.  Lower airway disease caused by respiratory syncytial virus.

Authors:  R Aggarwal
Journal:  Indian J Pediatr       Date:  1998 May-Jun       Impact factor: 1.967

5.  Concurrent bacterial infection and prolonged mechanical ventilation in infants with respiratory syncytial virus lower respiratory tract disease.

Authors:  Martin C J Kneyber; Heleen Blussé van Oud-Alblas; Margreet van Vliet; Cuno S P M Uiterwaal; Jan L L Kimpen; Adrianus J van Vught
Journal:  Intensive Care Med       Date:  2005-04-01       Impact factor: 17.440

6.  The impact of prophylaxis on paediatric intensive care unit admissions for RSV infection: a retrospective, single-centre study.

Authors:  Michelle L Butt; Amanda Symington; Marianne Janes; Louann Elliott; Susan Steele; Bosco A Paes
Journal:  Eur J Pediatr       Date:  2010-12-22       Impact factor: 3.183

7.  Predictors and incidence of hospitalization due to respiratory syncytial virus (RSV)-associated lower respiratory tract infection (LRTI) in non-prophylaxed moderate-to-late preterm infants in Bosnia and Herzegovina.

Authors:  Hajrija Maksić; Suada Heljić; Fahrija Skokić; Darinka Šumanović-Glamuzina; Veroslava Milošević; Almir Zlatanović; Notario Gerard
Journal:  Bosn J Basic Med Sci       Date:  2018-08-01       Impact factor: 3.363

8.  The clinical picture presented by premature neonates infected with the respiratory syncytial virus.

Authors:  J Forster; R F Schumacher
Journal:  Eur J Pediatr       Date:  1995-11       Impact factor: 3.183

9.  Role of ECMO in the treatment of respiratory syncytial virus bronchiolitis: a collaborative report.

Authors:  J Y Khan; S J Kerr; A Tometzki; L Tyszczuk; J West; A Sosnowski; D McCrae; C Skeoch; C Davis; R K Firmin
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-09       Impact factor: 5.747

10.  Predictors of prolonged length of hospital stay for infants with bronchiolitis.

Authors:  Carlos E Rodríguez-Martínez; Monica P Sossa-Briceño; Gustavo Nino
Journal:  J Investig Med       Date:  2018-03-26       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.